Diet Pills Market Size & Trends | Forecast 2021, 2028

Diet Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Prescription, Over the Counter Drugs and Herbal Supplements), Application (Appetite Suppression, Fat Blocking, Metabolism Raising Pills, and Others), Age Group (Teenagers and Adults), and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies & Drug Stores)

Publication Month : Mar 2022

  • Report Code : TIPRE00028374
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 182
Inquire Before Buy

PRICING

$4550

$3640

The diet pills market is expected to grow from US$ 1,132.55 million in 2021 to US$ 2,270.94 million by 2028; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028.

Diet pills are tablets used in conjunction with a good diet and exercise routine to help people lose weight. There are various options, but the NHS considers most of them ineffective. A few diet pills may be useless to help people lose weight, while others may be effective yet too dangerous to consume. Phentermine and topiramate-containing weight loss tablets have been proved to help people lose weight. The increase in self-care, the rising problem of obesity, an increase in the elderly population, and a surge in women taking dietary supplements are also expected to contribute to the growth of the diet pills market size.The diet pills market is segmented based on product type, application, age group, distribution channel, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The diet pills market report offers insights and in-depth analysis of the market, emphasizing market trends, technological advancements, market dynamics, and the competitive analysis of the globally leading market players.      

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Diet Pills Market: Strategic Insights

diet-pills-market
Market Size Value inUS$ 1,132.55 million in 2021
Market Size Value byUS$ 2,270.94 million by 2028
Growth rateCAGR of 10.4% from 2021 to 2028.
Forecast Period2021- 2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst



Lucrative Regions for Diet Pills Market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

New Product Launches by Market Players to Drive Diet Pills Market

In terms of the modern healthcare scenario, obesity is a massive concern globally. Obesity can give rise to several other associated chronic conditions, such as diabetes and cardiovascular diseases, which are the main concerns. Using specific prescription and over-the-counter drugs may help individuals struggling with effective weight management. The medication works in many ways to aid in effective weight management. A few of these diet pills may block fat absorption and suppress the appetite to aid weight management. Hence, increasing prevalence and concerns with obesity are expected to support the growth of the diet pills market during the forecast period.

Following are a few examples of companies that launched new diet pills and developments:

  • In February 2022, Iovate Health Sciences International Inc., under its nationally recognized Hydroxycut weight loss supplement brand, announced a new National US brand campaign, “No Fads. Just Weight Loss.” The campaign aims to highlight a three-step weight-loss journey.
  • In February 2020, VIVUS LLC and Alvogen—a Korean marketing partner, launched Qsymia (phentermine and topiramate extended-release) in the Republic of Korea. VIVUS LLC signed an agreement with Alvogen, an established leader in the South Korean anti-obesity market, to maximize the value of commercial-stage assets efficiently and cost-effectively.

Such developments by market players are driving the diet pills market.

Product Type Insights

Based on product type, the global diet pills market is segmented into prescription, over the counter drugs, herbal supplements. In 2021, the prescription segment held the largest share of the market. However, the herbal supplements segment is expected to register the highest CAGR during 2021–2028. The rising interest in natural products and preventative healthcare and a surge in spending on health and wellbeing are among the primary drivers of the herbal supplements segment growth. 

Diet Pills Market, by Product Type – during 2021–2028

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Application Insights

Based on application, the global diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. In 2021, the appetite suppression segment held the largest market share; it is expected to register the highest CAGR during 2021–2028. The appetite suppressing supplement does not contain caffeine or other stimulants; however, it can increase energy and focus. The person is more likely to stick with the workout routine and maintain a healthy lifestyle with more energy. Hence, these reasons are likely to boost the segment growth during the forecast period.

Product launches and collaborations are highly adopted strategies by the global diet pills market players. A few of the recent key market developments are listed below:

  • In December 2021, Pfizer Inc. acquired Arena Pharmaceuticals for ~US$ 6.7 billion to reshape its portfolio of inflammation drugs. Furthermore, Pfizer was uniquely positioned to acquire more assets.
  • In September 2019, Currax Pharmaceuticals LLC acquired Nalpropion Pharmaceuticals, Inc. As a result of this acquisition, Currax owned the worldwide rights to CONTRAVE, which is the number one prescribed weight-loss brand medication in the US.

The companies engaged in the diet pills market witnessed an adverse impact on their services in early 2020 due to the temporary shutdown of their laboratories. However, research laboratories reopened globally after the upliftment of lockdown. As a result, many service providers prioritized a few critical actions of the consumers during the COVID-19 pandemic, such as giving a range of high-quality COVID-19 related research tools; reassigning R&D resources for producing essential products; expanding the supply chain; supporting increased demand for COVID-19-related research products; and entering into discussions and collaborations across the UK, the US, and China concentrated on SARS-CoV-2 diagnostics, drugs, and vaccines development. Moreover, sales of dietary supplements for immune health increased after the emergence of the COVID-19 outbreak. Many people hoped that these products might protect consumers against SARS-CoV-2 infection and reduce disease severity in COVID-19 patients.

However, the lockdown disrupted the product supply chain and caused problems with raw material collection, thus affecting the market minimally. This pandemic is affecting the operations of the various key players operating in this region

Diet Pills– Market Segmentation

The global diet pills market is segmented based on product type, application, age group, distribution channel, and geography. Based on product type, the market is segmented into prescription, over the counter drugs, and herbal supplements. Based on application, the diet pills market is segmented into appetite suppression, fat blocking, metabolism raising pills, and others. Based on age range, the diet pills market is bifurcated into teenagers and adults. Based on distribution channel, the diet pills market is segmented into hospital pharmacies, online pharmacies, and retail pharmacies & drug stores. By geography, the diet pills market is segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America.  

Company Profiles

  • Novo Nordisk A/S
  • Gelesis
  • VIVUS LLC
  • Chong's Health Care
  • GlaxoSmithKline plc.
  • Pfizer Inc. (Arena Pharmaceutical GmbH)
  • Iovate Health Sciences International Inc.
  • Zoller Laboratories
  • Currax Pharmaceuticals LLC.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type, Application, Age Group, and Distribution Channel

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is the diet pills market?

Diet pills are tablets that are used in conjunction with a good diet and exercise routine to help people lose weight. There are a variety of options, but the NHS considers most of them ineffective. Some diet pills may be useless in helping people lose weight, while others may be effective yet too dangerous to use. Phentermine and topiramate-containing weight loss tablets have been proved to help people lose weight.

What are the driving factors for the diet pills market across the country?

Factors such as the increase in self-directed care, rising problem of obesity, and increase in elderly population & surge in women taking dietary supplements are driving the market. However, the challenging regulatory environment is expected to restrict the market growth during the forecast period.

What are the driving factors for the diet pills market across the country?

The challenging regulatory environment is expected to restrict the market growth during the forecast period

Who are the major players in market the diet pills market?

The diet pills market majorly consists of the players such as Novo Nordisk A/S, Gelesis, VIVUS LLC, Chong's Health Care, GlaxoSmithKline plc., Pfizer Inc. (Arena Pharmaceutical GmbH), Iovate Health Sciences International Inc., Zoller Laboratories, Currax Pharmaceuticals LLC., TEVA PHARMACEUTICAL INDUSTRIES LTD.

Which segment is dominating the diet pills market?

The global diet pills market based on product type, is segmented into prescription, over the counter drugs, and herbal supplements. In 2021, prescription segment held largest market share. However, herbal supplements segment is estimated to grow at the fastest CAGR of 10.9% during the forecast period.

Which region is dominating the diet pills market?

The global diet pills market on region, is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and the South & Central America. In 2021, North American region held largest market share. However, Asia Pacific region is estimated to grow at the fastest CAGR of 11.0% during the forecast period

The List Of Companies - Diet Pills Market

  1. Novo Nordisk A/S
  2. Gelesis
  3. VIVUS LLC
  4. Chong's Health Care
  5. GlaxoSmithKline plc.
  6. Pfizer Inc. (Arena Pharmaceutical GmbH)
  7. Iovate Health Sciences International Inc.
  8. Zoller Laboratories
  9. Currax Pharmaceuticals LLC.
  10. TEVA PHARMACEUTICAL INDUSTRIES LTD

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Diet Pills Market